Proteomic analysis enables distinction of early‐ versus advanced‐stage lung adenocarcinomas-Reference-Cited by-同舟云学术

Proteomic analysis enables distinction of early‐ versus advanced‐stage lung adenocarcinomas

Published:2020-06 Issue:2 Volume:10 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical and Translational Medicine

Author:

Kelemen Olga¹,Pla Indira¹²^ORCID,Sanchez Aniel¹²,Rezeli Melinda¹,Szasz Attila Marcell¹³⁴⁵,Malm Johan²⁵,Laszlo Viktoria⁶⁵,Kwon Ho Jeong¹⁴,Dome Balazs⁶⁵⁷,Marko‐Varga Gyorgy¹

Affiliation:

1. Clinical Protein Science and Imaging, Biomedical CenterDepartment of Biomedical EngineeringLund University Lund Sweden

2. Department of Translational MedicineLund University Malmö Sweden

3. Cancer CenterSemmelweis University Budapest Hungary

4. Chemical Genomics Global Research LabDepartment of BiotechnologyCollege of Life Science and BiotechnologyYonsei University Seoul Republic of Korea

5. Department of Tumor BiologyNational Korányi Institute of Pulmonology Budapest Hungary

6. Department of SurgeryDivision of Thoracic SurgeryComprehensive Cancer CenterMedical University of Vienna Vienna Austria

7. Department of Thoracic SurgerySemmelweis University and National Institute of Oncology Budapest Hungary

Funder

National Research Foundation of Korea

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.106

Reference127 articles.

1. Current status of research and treatment for non-small cell lung cancer in never-smoking females

2. Lung Cancer: Epidemiology, Etiology, and Prevention

3. Mutational heterogeneity in cancer and the search for new cancer-associated genes

4. Comprehensive molecular profiling of lung adenocarcinoma

5. EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteomic analyses identify HK1 and ATP5A to be overexpressed in distant metastases of lung adenocarcinomas compared to matched primary tumors;Scientific Reports;2023-11-28

2. Optimization of reversed‐phase solid‐phase extraction for shotgun proteomics analysis;Journal of Mass Spectrometry;2023-07-18

3. In‐depth proteomic analysis reveals unique subtype‐specific signatures in human small‐cell lung cancer;Clinical and Translational Medicine;2022-09

4. Proteomic Analysis of Lung Cancer Types—A Pilot Study;Cancers;2022-05-26

5. A prediction model integrated genomic alterations and immune signatures of tumor immune microenvironment for early recurrence of stage I NSCLC after curative resection;Translational Lung Cancer Research;2022-01